Category - Drug discovery

Oracle, Cleveland Clinic, and G42 Announce Strategic Partnership to Launch AI-Based Global Healthcare Delivery Platform

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

Cloud for AI/ML & Modern Data Science

Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

Industry News – 2024

2024 in Review

The Multifaceted and Sometimes Paradoxical Nature of Reactive Oxygen Species in Cancer

TLDR; The Value of Drugs for Rare Disease Indications May Be Higher Than You Think – Assets for Neurodevelopmental Disorders Alone May Be Worth Beyond USD $420B.

Novel Genetic Priority Score (GPS) Unveiled to Enhance Target Prioritization in Drug Development

The FDA’s Center for Drug Evaluation and Research (CDER) Approved 55 New Drugs in 2023

L7 Informatics Manages and Supports the Entire Lab Workflow from Sample Processing to Data Analysis and Insight Generation Employing Workflow Orchestration

The Role of the Human Gut Microbiome in Alzheimer’s Disease Development

Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine

ONTOFORCE Wants to Increase Data Literacy and Empower Citizen Data Scientists

Deepcell Aims to Create a Single Cell Morpholome Platform

We Invite you to join enlightenbio’s Subject Matter Expert Network!

Copyright © 2026. enlighenbio LLC. All rights reserved.